Renerve LimitedASX: RNV

Quarterly Report Webinar

· Issued by ReNerve Limited via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

The webinar will be led by CEO Dr. Julian Chick and is scheduled for a specific time on a Monday. The company focuses on innovative products for peripheral nerve injury repair and has shown significant clinical success with its flagship product. Renerve is advancing a comprehensive product portfolio aimed at improving surgical outcomes for patients worldwide.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/quarterly-report-webinar

Release

ASX Announcement 26 October 2026 Quarterly Report Webinar 11am (AEDT) Monday 2 November 2026 ReNerve Limited (ASX, "ReNerve" or "the Company"), an Australian biotechnology company developing innovative products for peripheral nerve injury ("PNI") repair, is hosting an investor webinar to provide an...

Renerve Limited on 6ix

Story so far

Earlier from Renerve

Later from Renerve

All Renerve news releases